Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported $7.35M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 42.1B 1.19B Mar/2026
Actinium Pharmaceuticals USD 7.35M 620K Mar/2026
Amgen USD 24.96B 534M Mar/2026
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Pfizer USD 34.35B 2.64B Mar/2026